miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by

Silvia Galardi1, Neri Mercatelli, Ezio Giorda

  • 1Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, Via Montpellier, 1 00133 Rome, Italy.

Insights

MicroRNAs miR-221 and miR-222 are overexpressed in aggressive prostate cancer, driving tumor growth by down-regulating the p27(Kip1) tumor suppressor. This suggests they act as oncogenes in prostate carcinoma progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • RNA Biology

Background:

  • MicroRNAs (miRNAs) regulate gene expression post-transcriptionally and are implicated in cancer pathogenesis.
  • Prostate carcinoma exhibits varying growth rates, with aggressive forms potentially linked to specific miRNA profiles.

Purpose of the Study:

  • To investigate the role of miR-221 and miR-222 in prostate carcinoma progression.
  • To identify the molecular targets and functional consequences of miR-221/222 overexpression in prostate cancer cells.

Main Methods:

  • Comparative analysis of miR-221/222 expression in prostate cancer cell lines with different growth rates.
  • Luciferase assays to validate p27(Kip1) as a direct target of miR-221/222.
  • Cell cycle analysis and soft agar colony formation assays to assess functional impact.
  • Antisense locked nucleic acid (LNA) oligonucleotides for miRNA knock-down experiments.

Main Results:

  • miR-221 and miR-222 were overexpressed in aggressive PC3 prostate cancer cells compared to slower-growing LNCaP and 22Rv1 cells.
  • A direct inverse correlation was observed between miR-221/222 levels and the cell cycle inhibitor p27(Kip1).
  • Ectopic miR-221/222 overexpression in LNCaP cells led to p27(Kip1) down-regulation, cell cycle progression (G1 to S shift), and enhanced colony formation.
  • Knock-down of miR-221/222 in PC3 cells increased p27(Kip1) levels and reduced clonogenicity.

Conclusions:

  • miR-221 and miR-222 function as oncogenes in prostate carcinoma by directly targeting the tumor suppressor p27(Kip1).
  • Overexpression of miR-221/222 contributes to prostate cancer oncogenesis and progression via p27(Kip1) down-regulation.
  • These miRNAs represent potential therapeutic targets for prostate cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...